Levings MK - Search Results

1

Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.

Patterson SJ, Han JM, Garcia R, Assi K, Gao T, O'Neill A, Newton AC, Levings MK. Patterson SJ, et al. Among authors: levings mk. J Immunol. 2011 May 15;186(10):5533-7. doi: 10.4049/jimmunol.1002126. Epub 2011 Apr 15. J Immunol. 2011. PMID: 21498666 Free PMC article.

2

IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms.

Levings MK, Schrader JW. Levings MK, et al. J Immunol. 1999 May 1;162(9):5224-9. J Immunol. 1999. PMID: 10227996

3

IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. Levings MK, et al. J Immunol. 2001 May 1;166(9):5530-9. doi: 10.4049/jimmunol.166.9.5530. J Immunol. 2001. PMID: 11313392

4

Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells.

Levings MK, Roncarolo MG. Levings MK, et al. Curr Top Microbiol Immunol. 2005;293:303-26. doi: 10.1007/3-540-27702-1_14. Curr Top Microbiol Immunol. 2005. PMID: 15981486 Review.

5

Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells.

Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK. Crellin NK, et al. Among authors: levings mk. J Immunol. 2005 Dec 15;175(12):8051-9. doi: 10.4049/jimmunol.175.12.8051. J Immunol. 2005. PMID: 16339542

6

Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells.

Crellin NK, Garcia RV, Levings MK. Crellin NK, et al. Among authors: levings mk. Blood. 2007 Mar 1;109(5):2014-22. doi: 10.1182/blood-2006-07-035279. Epub 2006 Oct 24. Blood. 2007. PMID: 17062729 Free article.

7

Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.

Levings MK, Allan S, d'Hennezel E, Piccirillo CA. Levings MK, et al. Adv Immunol. 2006;92:119-55. doi: 10.1016/S0065-2776(06)92003-3. Adv Immunol. 2006. PMID: 17145303 Review.

8

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. Allan SE, et al. Among authors: levings mk. Int Immunol. 2007 Apr;19(4):345-54. doi: 10.1093/intimm/dxm014. Epub 2007 Feb 27. Int Immunol. 2007. PMID: 17329235

9

Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.

Crellin NK, Garcia RV, Levings MK. Crellin NK, et al. Among authors: levings mk. J Immunol Methods. 2007 Jul 31;324(1-2):92-104. doi: 10.1016/j.jim.2007.05.008. Epub 2007 Jun 11. J Immunol Methods. 2007. PMID: 17582431

10

Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

Allan SE, Alstad AN, Merindol N, Crellin NK, Amendola M, Bacchetta R, Naldini L, Roncarolo MG, Soudeyns H, Levings MK. Allan SE, et al. Among authors: levings mk. Mol Ther. 2008 Jan;16(1):194-202. doi: 10.1038/sj.mt.6300341. Epub 2007 Nov 6. Mol Ther. 2008. PMID: 17984976 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters